Neuronetics, Inc. — Director's Dealing 2018

Jun 28, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2018-06-27

Reporting Person: Donato Peter (Vice President and CFO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$3.19	2027-04-11	Common Stock (104951)		Direct
Employee Stock Option (Right to Buy)	$2.32	2027-07-19	Common Stock (16572)		Direct
Employee Stock Option (Right to Buy)	$4.64	2028-03-15	Common Stock (30686)		Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F2: Twenty-five percent (25%) of the shares subject to the option shall vest on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F3: Twenty-five percent (25%) of the shares subject to the option shall vest on March 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.